Evolent Health Inc (EVH) : $1.21 million worth of transactions were on upticks in Evolent Health Inc (EVH), compared to $0.56 million on downticks. The ratio between the two was 2.16, whereas, the net money flow stood at a healthy $0.65 million on Fridays session. The consistent buying on upticks in the stock accounted for $0.62million worth of trades. The total money flow into the stock stood at $0.62 million. The bulls and the bears were in an equilibrium as the stock closed with a loss of -0.36%. The stock was trading at $24.94, with a drop of $0.09 over the previous days close. The stock recorded 0.12% for the week.
The company Insiders own 8.85% of Evolent Health Inc shares according to the proxy statements. Institutional Investors own 42.07% of Evolent Health Inc shares.
In a related news,The (Principal Accounting Officer) of Evolent Health, Inc., Stone Lydia sold 1,000 shares at $25.66 on August 15, 2016. The Insider selling transaction had a total value worth of $25,660. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Evolent Health Inc (NYSE:EVH): stock was range-bound between the intraday low of $24.83 and the intraday high of $25.25 after having opened at $25.07 on Fridays session. The stock finally closed in the red at $25.07, a loss of -0.36%. The stock remained in the red for the whole trading day. The total traded volume was 154,040 shares. The stock failed to cross $25.25 in Fridays trading. The stocks closing price on Thursday was $25.03.
Evolent Health Inc (EVH) : During the past 4 weeks, traders have been relatively bearish on Evolent Health Inc (EVH), hence the stock is down -0.51% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.38% relative to the S&P 500. The stock has risen by 0.12% in the past week indicating that the buyers are active at lower levels, but the stock is down -0.64% in the past 4 weeks.
Evolent Health, Inc. is engaged in the healthcare delivery and payment markets. The Companys platform enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to value-based payment models. It provides an end-to-end, technology-enabled services platform for providers to transition their organization in value-based payment models. It markets and sells services to providers throughout the United States. The Company works with its partners in two phases. In the transformation phase, it works with its partners to develop a plan for their transition to a value-based care model. During the second portion of the transformation phase, the Company works with its partner to implement the Blueprint. During the transformation phase, the Company seeks to enter into long-term agreements with its partners. In the platform and operations phase, the Company establishes a local market presence and embeds its resources alongside the Companys partners.